Use of sorafenib in two metastatic renal cell cancer patients with end-stage renal impairment undergoing replacement hemodialysis.

Ferraris, Elisa; Di Cesare, Pamela; Lasagna, Angioletta; Paglino, Chiara; Imarisio, Ilaria; Porta, Camillo

Ferraris, Elisa; Di Cesare, Pamela; Lasagna, Angioletta; Paglino, Chiara; Imarisio, Ilaria; Porta, Camillo.

Affiliation

Ferraris E; Oncologia Medica, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Tumori ; 95(4): 542-4, 2009.

Article in En | MEDLINE | ID: mdl-19856673

Subject(s)

Antineoplastic Agents/therapeutic use; Benzenesulfonates/therapeutic use; Carcinoma, Renal Cell/drug therapy; Kidney Neoplasms/drug therapy; Neoplasm Recurrence, Local/drug therapy; Pyridines/therapeutic use; Renal Dialysis; Carcinoma, Renal Cell/complications; Humans; Kidney Failure, Chronic/etiology; Kidney Failure, Chronic/therapy; Kidney Neoplasms/complications; Male; Middle Aged; Niacinamide/analogs & derivatives; Phenylurea Compounds; Sorafenib

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Pyridines / Benzenesulfonates / Carcinoma, Renal Cell / Renal Dialysis / Kidney Neoplasms / Neoplasm Recurrence, Local / Antineoplastic Agents Type of study: Etiology_studies Limits: Humans / Male / Middle aged Language: En Year: 2009 Type: Article

Search on Google

XML

PubMed Links